British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire

Published: 2014-06-09 15:58:48

Updated: 2014-06-09 15:58:48

British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire.

The biggest change due to Shire's entry is expected to be in the ADHD (attention deficit hyperactivity disorder) drug market. Shire is holding the market-leading products and a large number of products in ADHD drug market in the United States.

Accor...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.